Forbion Capital Fund IV Cooperatief U.A.

Sociétés où Forbion Capital Fund IV Cooperatief U.A. a négocié

• NewAmsterdam Pharma Co N.V.4 tx · $2.2M · Dec 30, 2024
• Dyne Therapeutics, Inc.3 tx · Sep 23, 2020

Historique de performance de Forbion Capital Fund IV Cooperatief U.A.

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Forbion Capital Fund IV Cooperatief U.A.

Co-initiés de Forbion Capital Fund IV Cooperatief U.A.

• Atlas Venture Associates Opportunity II, LPDyne Therapeutics, Inc.
• Atlas Venture Associates Opportunity I, LLCDyne Therapeutics, Inc.
• Atlas Venture Associates XI, LLCDyne Therapeutics, Inc.
• Atlas Venture Associates XI, L.P.Dyne Therapeutics, Inc.
• Atlas Venture Fund XI, L.P.Dyne Therapeutics, Inc.
• Atlas Venture Opportunity Fund II, L.P.Dyne Therapeutics, Inc.
• Audet Juliette BerangereNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Fund III, L.P.NewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Fund II, L.P.NewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences III General Partner, LLCNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Investors II, LLCNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Investors, LLCNewAmsterdam Pharma Co N.V.
• BCIP Life Sciences Associates, LPNewAmsterdam Pharma Co N.V.
• BCLS Fund III Investments GP, LLCNewAmsterdam Pharma Co N.V.
• BCLS Fund III Investments, LPNewAmsterdam Pharma Co N.V.
• BCLS II Investco, LPNewAmsterdam Pharma Co N.V.
• BCLS II Investo (GP), LLCNewAmsterdam Pharma Co N.V.
• Beskrovnaya OxanaDyne Therapeutics, Inc.
• Brumm Joshua TDyne Therapeutics, Inc.
• COX JOHNDyne Therapeutics, Inc.
• CureDuchenne Ventures, LLCDyne Therapeutics, Inc.